Медицинская профилактика: определение, цели, уровни, этапы, меры

DOI: https://doi.org/10.29296/25877305-2020-12-02
Скачать статью в PDF
Номер журнала: 
12
Год издания: 
2020

К.Р. Амлаев, доктор медицинских наук, профессор Ставропольский государственный медицинский
университет E-mail: kum672002@mail.ru

Статья посвящена актуальной теме – медицинской профилактике неинфекционных заболеваний (НИЗ). На основе анализа научной литературы дано описание факторов риска, их взаимосвязи и взаимовлияния, представлена трактовка этапов медицинской профилактики с примерами их реализации. В работе отражены стратегии медицинской профилактики и ее уровни, а также формы и методы работы. Подчеркнуто значение проведения своевременного скрининга НИЗ. Отмечается персональная роль врача в реализации эффективной медицинской профилактики.
Ключевые слова: 
медицинская профилактика
укрепление здоровья
стратегии профилактики
Для цитирования
К.Р. Амлаев Медицинская профилактика: определение, цели, уровни, этапы, меры . Врач, 2020; (12): 11-15 https://doi.org/10.29296/25877305-2020-12-02

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

Список литературы: 
  1. Jekel J.F., Katz D.L., Elmore J.G. Epidemiology, Biostatistics, and Preventive Medicine. 3 ed. W.B. Saunders Company, 2007.
  2. WHO. Noncommunicable diseases. URL: http://www.who.int/topics/noncommunicable_diseases/en/
  3. CDC. Noncommunicable Diseases: About Use. URL: http://www.cdc.gov/globalhealth/healthprotection/ncd/about.html
  4. Daar A.S., Singer P.A., Persad D.L. et al. Grand challenges in chronic non-communicable diseases. Nature. 2007; 450: 494–6. DOI: 10.1038/450494a
  5. Global Status Report on Noncommunicable Diseases 2010. World Health Organization, Ed. 2011.
  6. CDC. CDC Global Noncommunicable Diseases (NCDs). URL: http://www.cdc.gov/globalhealth/healthprotection/ncd/
  7. NIH’s GACD members are the National Heart, Lung and Blood Institute (NHLBI), National Cancer Institute (NCI), National Institute of Mental Health (NIMH), and Fogarty International Center (FIC). GACD. Alliance members. URL: https://www.gacd.org/about/people-and-organisation/alliance-members; GACD. About. URL: http://www.gacd.org/about
  8. Lee I.M., Shiroma E.J., Lobelo F. et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012; 380 (9838): 219–29. DOI: 10.1016/S0140-6736(12)61031-9
  9. Nordic Nutrition Recommendations 2004, 2005. URL: http://www.norden.org/en/publications/publikationer/2004–013
  10. Bauman A.E., Reis R.S., Sallis J.F. et al. Correlates of physical activity: why are some people physically active and others not? Lancet. 2012; 380 (9838): 258–71. DOI: 10.1016/S0140-6736(12)60735-1
  11. Chapter 6: Accelerometry in children. In: Craig R., Mindell J.V.H. eds Health SURVey for England 2008: physical activity and fitness. Leeds: Health and Social Care Information Centre, 2009: 160–73.
  12. Ng S.W., Popkin B.M. Time use and physical activity: a shift away from movement across the globe. Obes Rev. 2012; 13 (8): 659–80. DOI: 10.1111/j.1467-789X.2011.00982.x
  13. Lim S.S., Vos T., Flaxman A.D. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013; 380 (9859): 2224–60. https://doi.org/10.1016/S0140-6736(12)61766-8
  14. Lee I.M., Shiroma E.J., Lobelo F. et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012; 380 (9838): 219–29. DOI: 10.1016/S0140-6736(12)61031-9
  15. Owen N., Healy G.N., Matthews C.E. Too much sitting: the population health science of sedentary behavior. Exerc Sport Sci REV. 2010; 38 (3): 105–13. DOI: 10.1097/JES.0b013e3181e373a2
  16. Dunstan D.W., Thorp A.A., Healy G.N. Prolonged sitting: is it a distinct coronary heart disease risk factor? Curr Opin Cardiol. 2011; 26 (5): 412–19. DOI: 10.1097/HCO.0b013e3283496605
  17. Healy G.N., Eakin E.G., Lamontagne A.D. Reducing sitting time in office workers: short-term efficacy of a multicomponent intervention. PrEV Med. 2013; 57 (1): 43–8. DOI: 10.1016/j.ypmed.2013.04.004
  18. Lee D.C., Sui X., Church T.S. et al. Changes in fitness and fatness on the development of cardiovascular disease risk factors hypertension, metabolic syndrome, and hypercholesterolemia. J Am Coll Cardiol. 2012; 59 (7): 665–72. DOI: 10.1016/j.jacc.2011.11.013
  19. Bacon L., Aphramor L. Weight science: evaluating the evidence for a paradigm shift. Nutr J. 2011; 10: 9. DOI: 10.1186/1475-2891-10-9
  20. Агафонова О.В., Гриценко Т.А., Богданова Ю.В. и др. Поликлиническая терапия: Учебник. Под ред. Д.И. Давыдкина, Ю.В. Щукина. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2020; 840 с. [Agafonova O.V., Gritsenko T.A., Bogdanova Yu.V. et al. Poliklinicheskaya terapiya: Uchebnik. Pod red. D.I. Davydkina, Yu.V. Shchukina. 2-e izd., pererab. i dop. M.: GEOTAR-Media, 2020; 840 s. (in Russ.)] DOI: 10.33029/9704-5545-6-PLT-2020-1-840
  21. Adler N.E., Stewart J. Reaching for a Healthier Life: Facts on Socioeconomic Status and Health in the U.S. In The John D. and Catherine T. Macarthur Foundation Research Network on Socioeconomic Status and Health, 2007.
  22. WHO, Global strategy to reduce harmful use of alcohol, 2010.
  23. WHO, Global action plan for the prevention and control of NCDs, 2013–2020,
  24. 66th WHA. Follow-up to the Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-Communicable Diseases. WHA66.10, May 27, 2013. URL: https://apps.who.int/iris/handle/10665/15016.1
  25. Jiamsripong P., Mookadam M., Honda T. et al. The metabolic syndrome and cardiovascular disease: Part I. Prev Cardiol. 2008; 11 (3): 155–61. https://doi.org/10.1111/j.1751-7141.2008.07809.x
  26. AHRQ. 2008. Guide to Clinical Preventive Services. U.S. Preventive Services Task Force 2008. Available from: http://www.ahrq.gov/clinic/cps3dix.htm
  27. Chiolero A., Paradis G., Paccaud F. The pseudo-high-risk prevention strategy. Int J Epidemiol. 2015; 44 (5): 1469–73. DOI: 10.1093/ije/dyv102
  28. Katz D., Ali A. Preventive medicine, integrative medicine, and the health of the public. Commissioned IOM Summit Integr Med Health Public, 2009.
  29. Committee on Depicting Innovation in Information Technology, Computer Science and Telecommunications Board, Division on Engineering and Physical Sciences NRC. Continuing innovation in information technology. Washington, DC: The National Academies Press, 2012.
  30. Fogg B.J. Creating persuasive technologies: an eight-step design process. 4th International conference on persuasive technology. New York: ACM, 2009.
  31. Matheson G.O., Klügl M., Engebretsen L. Prevention and management of non-communicable disease: the IOC consensus statement, Lausanne 2013. Sports Med. 2013; 43 (11): 1075–88. DOI: 10.1007/s40279-013-0104-3